Last updated on November 2017

Study for Schizophrenia Patients with Alcohol Use Disorder


Brief description of study

Study for Schizophrenia Patients with Alcohol Use Disorder

Detailed Study Description

A Phase II, Randomized, Double-blind Study to Evaluate Efficacy, Safety, and Tolerablity of ALKS 3831 in Subjects with Schizophrenia with Alcohol Use Disorder

Clinical Study Identifier: TX7078

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Segal Institute for Clinical Research ...

Segal Institute for Clinical Research - Carolina Clinical Trials, Inc.
Charleston, SC USA
  Connect »

Segal Institute for Clinical Research ...

Segal Institute for Clinical Research - Innovative Clinical Research, Inc.
Lauderhill, SC USA
  Connect »